Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 355

1.

Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species.

Silvie O, Greco C, Franetich JF, Dubart-Kupperschmitt A, Hannoun L, van Gemert GJ, Sauerwein RW, Levy S, Boucheix C, Rubinstein E, Mazier D.

Cell Microbiol. 2006 Jul;8(7):1134-46.

PMID:
16819966
2.

Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.

Silvie O, Rubinstein E, Franetich JF, Prenant M, Belnoue E, Rénia L, Hannoun L, Eling W, Levy S, Boucheix C, Mazier D.

Nat Med. 2003 Jan;9(1):93-6. Epub 2002 Dec 16.

PMID:
12483205
3.

Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites.

Silvie O, Charrin S, Billard M, Franetich JF, Clark KL, van Gemert GJ, Sauerwein RW, Dautry F, Boucheix C, Mazier D, Rubinstein E.

J Cell Sci. 2006 May 15;119(Pt 10):1992-2002.

4.

Alternative invasion pathways for Plasmodium berghei sporozoites.

Silvie O, Franetich JF, Boucheix C, Rubinstein E, Mazier D.

Int J Parasitol. 2007 Feb;37(2):173-82. Epub 2006 Oct 30.

PMID:
17112526
5.

CD81 is required for rhoptry discharge during host cell invasion by Plasmodium yoelii sporozoites.

Risco-Castillo V, Topçu S, Son O, Briquet S, Manzoni G, Silvie O.

Cell Microbiol. 2014 Oct;16(10):1533-48. doi: 10.1111/cmi.12309. Epub 2014 Jun 2.

PMID:
24798694
6.

Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain.

Yalaoui S, Zougbédé S, Charrin S, Silvie O, Arduise C, Farhati K, Boucheix C, Mazier D, Rubinstein E, Froissard P.

PLoS Pathog. 2008 Feb 29;4(2):e1000010. doi: 10.1371/journal.ppat.1000010.

7.

The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection.

Charrin S, Yalaoui S, Bartosch B, Cocquerel L, Franetich JF, Boucheix C, Mazier D, Rubinstein E, Silvie O.

J Biol Chem. 2009 Nov 13;284(46):31572-8. doi: 10.1074/jbc.M109.057927. Epub 2009 Sep 17.

8.

In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines.

Calvo-Calle JM, Moreno A, Eling WM, Nardin EH.

Exp Parasitol. 1994 Nov;79(3):362-73.

PMID:
7957756
9.

Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection.

Yalaoui S, Huby T, Franetich JF, Gego A, Rametti A, Moreau M, Collet X, Siau A, van Gemert GJ, Sauerwein RW, Luty AJ, Vaillant JC, Hannoun L, Chapman J, Mazier D, Froissard P.

Cell Host Microbe. 2008 Sep 11;4(3):283-92. doi: 10.1016/j.chom.2008.07.013.

10.

Exposure of Plasmodium sporozoites to the intracellular concentration of potassium enhances infectivity and reduces cell passage activity.

Kumar KA, Garcia CR, Chandran VR, Van Rooijen N, Zhou Y, Winzeler E, Nussenzweig V.

Mol Biochem Parasitol. 2007 Nov;156(1):32-40. Epub 2007 Jul 13.

PMID:
17714805
11.

Molecular mechanism of host specificity in Plasmodium falciparum infection: role of circumsporozoite protein.

Rathore D, Hrstka SC, Sacci JB Jr, De la Vega P, Linhardt RJ, Kumar S, McCutchan TF.

J Biol Chem. 2003 Oct 17;278(42):40905-10. Epub 2003 Aug 6.

12.

Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.

Labaied M, Harupa A, Dumpit RF, Coppens I, Mikolajczak SA, Kappe SH.

Infect Immun. 2007 Aug;75(8):3758-68. Epub 2007 May 21.

13.

Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.

Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, Wang R, Kappe SH.

J Infect Dis. 2007 Aug 15;196(4):608-16. Epub 2007 Jul 9.

PMID:
17624848
14.

Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism.

Shear HL, Grinberg L, Gilman J, Fabry ME, Stamatoyannopoulos G, Goldberg DE, Nagel RL.

Blood. 1998 Oct 1;92(7):2520-6.

15.

[Plasmodium sporozoite entry pathways during malaria liver infection].

Risco-Castillo V, Son O, Franetich JF, Rubinstein E, Mazier D, Silvie O.

Biol Aujourdhui. 2013;207(4):219-29. doi: 10.1051/jbio/2013021. Epub 2014 Mar 5. French.

PMID:
24594570
16.

Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody.

Charoenvit Y, Mellouk S, Sedegah M, Toyoshima T, Leef MF, De la Vega P, Beaudoin RL, Aikawa M, Fallarme V, Hoffman SL.

Exp Parasitol. 1995 May;80(3):419-29.

PMID:
7729477
19.

Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection.

Aly AS, Mikolajczak SA, Rivera HS, Camargo N, Jacobs-Lorena V, Labaied M, Coppens I, Kappe SH.

Mol Microbiol. 2008 Jul;69(1):152-63. doi: 10.1111/j.1365-2958.2008.06271.x. Epub 2008 May 5.

20.

Supplemental Content

Support Center